Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
8.01
-0.40 (-4.76%)
At close: Aug 15, 2025, 3:59 PM
8.08
0.87%
After-hours: Aug 15, 2025, 06:49 PM EDT
Amylyx Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -187.6M | -218.86M | -301.74M | -259.47M | -165.87M | -71.09M | 49.27M | 1.84M | -72.81M | -148.95M | -198.38M | -184.01M | -153.4M | -121.26M | -87.93M | -68.18M | -45.04M | -23.11M |
Depreciation & Amortization | 678K | 745K | 904K | 1.04M | 1.13M | 1.2M | 1.09M | 969K | 832K | 656K | 487K | 327K | 172K | 77K | 52K | 31K | 21K | 11K |
Stock-Based Compensation | 27.73M | 29.95M | 33.04M | 35.83M | 39.2M | 39.58M | 37.16M | 33.72M | 29.07M | 24.82M | 21.71M | 16.71M | 11.99M | 6.94M | 3.14M | 2.17M | 1.36M | 707K |
Other Working Capital | -19.38M | -39.19M | -37.53M | 14.54M | -1.01M | 7.21M | 27.78M | 18.63M | 31.28M | 34.76M | 21.58M | 5.31M | -279K | 2.5M | 3.92M | 5.54M | 4.25M | -1.7M |
Other Non-Cash Items | 11.72M | 27.41M | 137.78M | 136.87M | 118.81M | 101.63M | -9.94M | -9.23M | -6.83M | -4.96M | -2.06M | 59.49M | 59.6M | 63.02M | 64.94M | 5.72M | 5.69M | 2.38M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -59.59M | -59.59M | -59.59M | -59.59M | n/a | n/a | n/a |
Change in Working Capital | -18.17M | -36.07M | -26.7M | 1.56M | -41.03M | -54.05M | -65.66M | -78.62M | -39.49M | -15.87M | -1.64M | 8.65M | 5.02M | 8.01M | 4.59M | 5.29M | 3.85M | -1.05M |
Operating Cash Flow | -165.65M | -206.98M | -167.65M | -95.09M | -58.69M | 16.5M | 11.92M | -51.33M | -89.24M | -144.31M | -179.87M | -158.42M | -136.21M | -102.79M | -74.8M | -55.44M | -34.58M | -21.53M |
Capital Expenditures | -29K | -101K | -157K | -493K | -869K | -1.06M | -1.24M | -1.5M | -1.61M | -2.43M | -2.53M | -2.09M | -1.79M | -681K | -353K | -318K | -165K | -165K |
Cash Acquisitions | n/a | n/a | n/a | -21.28M | 86.45M | 86.45M | 30.21M | 279.05M | 171.32M | 165.75M | 221.99M | -5.57M | -5.57M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -142.64M | -262.52M | -231.99M | -358.63M | -523.06M | -364.18M | -300.83M | -435.75M | -271.32M | -301.75M | -415.87M | -154.31M | -203.37M | -172.93M | -49.05M | -49.05M | n/a | n/a |
Sales Maturities Of Investments | 262M | 330M | 344M | 426.92M | 408.62M | 402.12M | 394.12M | 280.2M | 308M | 220.5M | 179.41M | 145.41M | 60.91M | 24.91M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -36.2M | -65.08M | -64.19M | -42.91M | -114.44M | 37.94M | 93.29M | -155.55M | 36.68M | -81.25M | -236.46M | -5.9M | -139.46M | -145.02M | -46.05M | -49.05M | n/a | n/a |
Investing Cash Flow | 83.13M | 31.18M | 75.65M | 31.6M | -115.31M | 36.88M | 92.05M | -157.05M | 35.08M | -83.68M | -238.99M | -7.99M | -141.24M | -145.7M | -46.41M | -49.37M | -165K | -165K |
Debt Repayment | 65.58M | 65.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 263K | 263K | 26.16M | 27.32M | 27.06M | 27.06M |
Common Stock Repurchased | 1.33M | 1.31M | n/a | -117K | -1.55M | -2.27M | -3.31M | -3.2M | -3.1M | -2.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 65.82M | 65.88M | 348K | 468K | 1.28M | 2.63M | 3.54M | 3.92M | 3.04M | 824K | -658K | -2.54M | -3.88M | -1.06M | -583K | 707K | 2.04M | 47K |
Financial Cash Flow | 65.82M | 65.88M | 348K | 468K | 1.28M | 2.63M | 3.54M | 235.47M | 234.59M | 232.37M | 431.79M | 198.56M | 330.21M | 333.03M | 158.51M | 160.75M | 29.1M | 27.11M |
Net Cash Flow | -15.46M | -109.34M | -91.36M | -61.98M | -172.76M | 55.99M | 107.67M | 27.52M | 180.62M | 4.46M | 12.87M | 31.59M | 52.58M | 84.49M | 37.31M | 55.94M | -5.64M | 5.41M |
Free Cash Flow | -165.68M | -207.08M | -167.8M | -95.58M | -59.56M | 15.44M | 10.68M | -52.83M | -90.84M | -146.74M | -182.4M | -160.51M | -137.99M | -103.47M | -75.15M | -55.76M | -34.74M | -21.7M |